The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Why Choose Us?   Results

Drugs Avandia Research Center

NEJM Study

in this section: Firm's Press Release, 10.1.07 | Another FDA Warning? 10.24.07 | avandia drug warning | Study Reveals Risks, 6.6.07 | FDA Warning, 5.22.07 | Secret Avandia Vote | Veterans Affairs: Avandia | FDA Approval of Avandia | NEJM Study | Warning Letter, 2001 | Sales Plunge | NEJM Update, 6.5.07 | FDA Safety Information | FDA Warning, 6.6.07 | Scientists Silenced | Dallas Lawsuit | Patients Switch Meds | Avandia Prescriptions Fall | Updated Study, 7.12.07 | Avandia Panel, 7.25.07 | Second Black Box? | Senators Testify | Experts Cite Risks | Black Box Warning | 9.12.07 Study Analysis | Actos Study | Arkansas Lawsuit | Weakens Bones | JAMA Report, 12.7.07 | Avandia Diabetes Pills | Avandia Warning

Bookmark This Page Print This Page Email This Page

New England Journal of Medicine on Rosiglitazone (Avandia) Medication

The New England Journal of Medicine has just released a study examining the link between the medication Rosiglitazone (marketed as Avandia, Avandamet, and Avandaryl) and cardiovascular problems such as heart attacks.

The study, which appears in the June 14, 2007 issue of the journal, analyzes over 40 existing clinical studies involving nearly 28,000 patients.

The authors concluded that Avandia significantly increased the risk of heart attacks, compared with other diabetes drugs or a placebo.

In the study's conclusions, the authors wrote that "patients and providers should consider the potential for serious adverse cardiovascular effects of treatment with rosiglitazone for type 2 diabetes."

In an interview with the New York Times, the study's lead author, Dr. Steven E. Nissen of the Cleveland Clinic, said that the average diabetic had a 20.2 percent risk of a heart attack over a seven-year period. "A diabetic taking Avandia," said Nissen, "has a 28.9 percent risk during that same seven-year time period," according to his analysis.

The research method used by Nissen and his colleagues, was a "meta-analysis," which combines the data of numerous studies.

If you or a loved one has suffered cardiac complications after ingesting Avandia, you deserve the guidance of an experienced drug attorney. Get a free case review by filling out the form below.

Click To Talk To Us Online

Please complete the following questionnaire:

When did you start taking Avandia?
What cardiovascular problems did you experience with the drug?
What was the date you experienced cardiac complications?
Did you have any cardiovascular disease before taking Avandia?
Do you smoke?
How did you learn of Weitz & Luxenberg?
Contact Name
Email Address
Phone Number (optional)


see also:

Scientists Silenced Scientists Silenced About the Dangers of Avandia--Attorney Resources
Editorial: Scientists Silenced About Avandia--Get an Avandia Attorney

Updated Study, 7.12.07 Latest News on Avandia: German Study Adds More Reasons to Avoid it
Latest Study in the News: Avandia May Worsen Complications of Diabetes

News & Warnings Avandia Breaking News: Glaxo Warned in 2001 about Misleading Marketing
Bloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here
for a free case review

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims

$25 million jury verdict — brake reliner

$5.8 million settlement — failure to perform timely C-Section

$30 million verdict — 7 former power-plant workers suffering from asbestos-related illnesses

$6 million settlement — pediatric malpractice case

$14 million consolidated verdict — 5 asbestos-related cancer suits: shipyards/powerhouses/construction

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$3.5 million — 2 asbestos exposure cases

$600,000 settlement — motor vehicle negligence resulting in serious injury

$44 million verdict — 5 asbestos cases, including $11.6 million awarded to widow of sheet metal worker who died of mesothelioma

$1.6 million settlement — suicide after premature hospital discharge

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$1.5 million settlement — construction worker fell off elevated train tracks

$750,000 settlement — defective construction equipment resulted in serious injury to worker


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.